Prosight Management, LP Paratek Pharmaceuticals, Inc. Transaction History

Prosight Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $1.2 Million - $2.24 Million	-450,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $1.32 Million - $2.03 Million	450,000 New	450,000 $1.81 Million
Q3 2018 Nov 15, 2018	SELL	$9.05 - $10.95 $1.31 Million - $1.59 Million	-144,752 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $40,086 - $54,627	-3,930 Reduced 2.64%	144,752 $1.48 Million
Q1 2018 May 14, 2018	SELL	$12.65 - $18.85 $376,603 - $561,183	-29,771 Reduced 16.68%	148,682 $1.93 Million
Q4 2017 Feb 13, 2018	BUY	$17.45 - $25.6 $3.11 Million - $4.57 Million	178,453	178,453 $3.19 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.